OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5926-5926
Open Access | Times Cited: 13
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5926-5926
Open Access | Times Cited: 13
Showing 13 citing articles:
Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence
Ashwin Mukund, Muhammad Ali Afridi, Aleksandra Karolak, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2240-2240
Open Access | Times Cited: 9
Ashwin Mukund, Muhammad Ali Afridi, Aleksandra Karolak, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2240-2240
Open Access | Times Cited: 9
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyón, Amaya López-Pascual, Borja Castelló-Uribe, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Daniel Oyón, Amaya López-Pascual, Borja Castelló-Uribe, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function
Ruth Nussinov
Journal of Molecular Biology (2025), pp. 169044-169044
Open Access
Ruth Nussinov
Journal of Molecular Biology (2025), pp. 169044-169044
Open Access
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Belén Toledo, Chiara Deiana, Fabio Scianò, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 323-347
Open Access | Times Cited: 3
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnès Basseville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Maryam Safari, Luigi Scotto, Agnès Basseville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma
Benjamin E. Stubbe, Anders Christian Larsen, Poul Henning Madsen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Benjamin E. Stubbe, Anders Christian Larsen, Poul Henning Madsen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Computational insights into KRAS G12C inhibition: exploring possible repurposing of Azacitidine and Ribavirin
Vishakha Sharma, Ankush Kumar, Ravi Rawat, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access | Times Cited: 1
Vishakha Sharma, Ankush Kumar, Ravi Rawat, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access | Times Cited: 1
Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382
Kai-Ru Zhuang, Chian‐Feng Chen, Hsin-Yu Chan, et al.
Phytomedicine (2024) Vol. 132, pp. 155860-155860
Closed Access | Times Cited: 1
Kai-Ru Zhuang, Chian‐Feng Chen, Hsin-Yu Chan, et al.
Phytomedicine (2024) Vol. 132, pp. 155860-155860
Closed Access | Times Cited: 1
Explainable multi-omics deep clustering model reveals an important role of DNA methylation in pancreatic ductal adenocarcinoma
A. Lopez, John Zobolas, Ole Christian Lingjærde, et al.
Nordic Machine Intelligence (2024) Vol. 4, Iss. 2, pp. 26-42
Open Access | Times Cited: 1
A. Lopez, John Zobolas, Ole Christian Lingjærde, et al.
Nordic Machine Intelligence (2024) Vol. 4, Iss. 2, pp. 26-42
Open Access | Times Cited: 1
PROGNOSTIC IMPACT OF PROMOTER-HYPERMETHYLATED SFRP1 IN PANCREATIC DUCTAL ADENOCARCINOMA: A BLOOD-BASED BIOMARKER STUDY
Benjamin E. Stubbe
(2024)
Open Access
Benjamin E. Stubbe
(2024)
Open Access
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function
Ruth Nussinov
(2024)
Closed Access
Ruth Nussinov
(2024)
Closed Access
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
Benjamin E. Stubbe, Poul Henning Madsen, Anders Christian Larsen, et al.
Pancreatology (2023) Vol. 23, Iss. 5, pp. 512-521
Open Access | Times Cited: 1
Benjamin E. Stubbe, Poul Henning Madsen, Anders Christian Larsen, et al.
Pancreatology (2023) Vol. 23, Iss. 5, pp. 512-521
Open Access | Times Cited: 1
